Abstract: Disclosed are methods and kits of parts useful in inhibiting biofilm formation in vivo in subjects at risk of developing biofilms. These methods include inhibiting biofilm formation where the extracellular matrix in the biofilm includes poly-?-(1?6)glucosamine structures.
Type:
Grant
Filed:
February 4, 2020
Date of Patent:
November 10, 2020
Assignee:
OneBioPharma, Inc.
Inventors:
Michael Wyand, John Donnelly, Gerald F. Swiss